Back to the Future? Immunoglobulin Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Healthcare (Basel) · 2021 · PMC8623195 · PMID 34828592

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

For example, the increase in Karnofsky performance scores [ 48 ] pre- and post -treatment is reported as highly significant in all groups, but with no significant difference between the groups.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.